National Coverage Determination 200.3: Monoclonal Antibodies for the Treatment of Alzheimer’s Disease

Related CR Release Date: May 23, 2024
Effective Date: April 7, 2022
Implementation Date: June 24, 2024
MLN Matters Number: MM13598
Related Change Request (CR) Number: CR 13598
Related CR Transmittal Number: R12649CP

CR 13598 tells you about:

  • FDA-approved monoclonal antibodies
  • Criteria for coverage
  • Coding information
  • Claims processing instructions

Make sure your billing staff knows about these changes.

View the complete CMS Medicare Learning Network (MLN) Matters (MM)13598.

Last Updated Jun 06 , 2024